Structural basis for human TRPC5 channel inhibition by two distinct inhibitors

• Published in: bioRxiv
• Main Authors: Song, Kangcheng, Miao, Wei, Guo, Wenjun, Kang, Yunlu, Jing-Xiang, Wu, Chen, Lei
• Format: Paper
• Language: English
• Published: Cold Spring Harbor Cold Spring Harbor Laboratory Press 21.04.2020
• Subjects: Anxiety disorders; Kidney diseases
• DOI: 10.1101/2020.04.21.052910

TRPC5 channel is a non-selective cation channel that participates diverse physiological processes. Human TRPC5 inhibitors show promise in the treatment of anxiety disorder, depression and kidney disease. Despite the high relevance of TRPC5 to human health, its inhibitor binding pockets have not been fully characterized due to the lack of structural information, which greatly hinders structure-based drug discovery. Here we show cryo-EM structures of human TRPC5 in complex with two distinct inhibitors, namely clemizole and HC-070, to the resolution of 2.7 A. Based on the high-quality cryo-EM maps, we uncover the different binding pockets and detailed binding modes for these two inhibitors. Clemizole binds inside the voltage sensor-like domain of each subunit, while HC-070 binds close to the ion channel pore and is wedged between adjacent subunits. Both of them exert the inhibitory function by stabilizing the ion channel in a closed state. These structures provide templates for further design and optimization of inhibitors targeting human TRPC5. Competing Interest Statement The authors have declared no competing interest.